Clinical trial highlights Special session

MITO 23: A randomized phase III trial on trabectedin vs physician choice chemotherapy in BRCA mut and BRCAness ovarian cancer

Lecture Time
11:25 - 11:35
Speakers
  • Domenica Lorusso (Rome, Italy)
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00